Literature DB >> 32358628

Feasibility of preserving the remnant stomach during distal pancreatectomy after distal gastrectomy.

Jiro Kimura1, Takehiro Okabayashi2, Kenta Sui1, Takatsugu Matsumoto1, Takahiro Murokawa1, Jun Iwata3, Sojiro Morita4, Yasuhiro Shimada5.   

Abstract

PURPOSE: The safety and feasibility of preserving the remnant stomach during distal pancreatectomy (DP) in patients who have undergone distal gastrectomy (DG) remains unclear.
METHODS: A retrospective review of a prospectively maintained database was performed to identify patients who underwent DP. A propensity score-matched analysis was performed to match post-DG patients with control patients.
RESULTS: Among the 226 patients included in this study, 9 DP patients who had a history of DG were studied (4.0%). These nine patients in the DG group were matched to 45 patients in the control group. There were no significant differences in the incidence of postoperative morbidities, including postoperative pancreatic fistula rate or stomach-related complications. The hemoglobin A1C (HbA1c) levels in the DG group after surgery decreased to the normal range.
CONCLUSION: Our study suggested that the remnant stomach may be safely preserved when performing DP in patients with a history of DG with respect to short-term morbidities. However, there are some concerns about the long-term nutritional status in patients with a history of DG.

Entities:  

Keywords:  Distal gastrectomy; Distal pancreatectomy; Stomach-related complications

Year:  2020        PMID: 32358628     DOI: 10.1007/s00595-020-02016-4

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  1 in total

1.  Safety of performing distal pancreatosplenectomy in patients who underwent distal gastrectomy previously: a multicenter cohort analysis with systematic literature review.

Authors:  Sung Eun Park; Kwang Yeol Paik; Dong Do You; Tae Yoon Lee; Kee-Hwan Kim; Gun Hyung Na; Jung Hyun Park; Tae Ho Hong
Journal:  Ann Surg Treat Res       Date:  2022-09-06       Impact factor: 1.766

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.